Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health
Richard L. Doty
Trends in Molecular Medicine (2022) Vol. 28, Iss. 9, pp. 781-794
Open Access | Times Cited: 68
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Valentina Leta, Daniele Urso, Lucia Batzu, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1119-1132
Open Access | Times Cited: 46
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Anamika Gupta, Hezlin Marzook, Firdos Ahmad
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 313-331
Open Access | Times Cited: 43
A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies
Changxing Li, Sobia Noreen, Lixue Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112550-112550
Open Access | Times Cited: 41
Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden
Jiangwei Sun, Jonas F. Ludvigsson, Caroline Ingre, et al.
PLoS Medicine (2022) Vol. 19, Iss. 9, pp. e1004092-e1004092
Open Access | Times Cited: 32
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
Marcell Szabo, Michiyo Iba, Avindra Nath, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 447-454
Open Access | Times Cited: 30
Early diagnosis of Parkinson's disease using Continuous Convolution Network: Handwriting recognition based on off-line hand drawing without template
Zhu Li, Jiayu Yang, Yanwen Wang, et al.
Journal of Biomedical Informatics (2022) Vol. 130, pp. 104085-104085
Open Access | Times Cited: 24
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Tingting Liu, Haojie Wu, Lin Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3259-3282
Open Access | Times Cited: 4
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret K. Huber, Günter U. Höglinger, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 28
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
Valentina Leta, Iro Boura, Daniel J. van Wamelen, et al.
International review of neurobiology (2022), pp. 63-89
Open Access | Times Cited: 21
COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent
Sebastián García Menéndez, Virna Margarita Martín Giménez, Michael F. Holick, et al.
Life Sciences (2022) Vol. 297, pp. 120464-120464
Open Access | Times Cited: 19
Neuropsychological measures of post-COVID-19 cognitive status
Alessandra Lauria, Angelo Carfì, Francesca Benvenuto, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 12
SARS-CoV-2 Spike Protein 1 Causes Aggregation of α-Synuclein via Microglia-Induced Inflammation and Production of Mitochondrial ROS: Potential Therapeutic Applications of Metformin
Moon Han Chang, Jung Hyun Park, Hye‐Kyung Lee, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1223-1223
Open Access | Times Cited: 4
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
Joy Mitra, Manohar Kodavati, Vincent E. Provasek, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101687-101687
Open Access | Times Cited: 16
Bioinformatics and Systems Biology Approaches to Identify the Synergistic Effects of Alcohol Use Disorder on the Progression of Neurological Diseases
Md Jahangir Alam, Md Habibur Rahman, Md. Arju Hossain, et al.
Neuroscience (2024) Vol. 543, pp. 65-82
Closed Access | Times Cited: 3
Effects of Continuous Dopaminergic Stimulation on Parkinson’s Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion
Gabriele Imbalzano, Carlo Alberto Artusi, Claudia Ledda, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 843-853
Open Access | Times Cited: 3
Severe Dyskinesia After Administration of SARS‐CoV2 mRNA Vaccine in Parkinson's Disease
Roberto Erro, Antonio Riccardo Buonomo, Paolo Barone, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2219-2219
Open Access | Times Cited: 18
Parkinson’s Disease, SARS-CoV-2, and Frailty: Is There a Vicious Cycle Related to Hypovitaminosis D?
Sara Palermo, Mario Stanziano, Anna Nigri, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 528-528
Open Access | Times Cited: 7
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
Iro Boura, Mubasher A. Qamar, Francesco Daddoveri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2524-2524
Open Access | Times Cited: 7
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID‐19 infection
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 2
The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson’s Disease: An Updated Systematic Review
Vikash Jaiswal, Danah Alquraish, Zouina Sarfraz, et al.
Journal of Primary Care & Community Health (2021) Vol. 12
Open Access | Times Cited: 17
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19
Mohammad Fathi, Fatemeh Taghizadeh, Hanieh Mojtahedi, et al.
Revue Neurologique (2021) Vol. 178, Iss. 1-2, pp. 129-136
Open Access | Times Cited: 17
Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment
Aurelian Anghelescu, Gelu Onose, Cristina Raluca Gh. Popescu, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1000-1000
Open Access | Times Cited: 11
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
Jaime R. Silva, Felipe Patricio, Aleidy Patricio-Martínez, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 11
Effects and parameters of community-based exercise on motor symptoms in Parkinson’s disease: a meta-analysis
Chunlan Yang, Jiapeng Huang, Tingting Wang, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top